MedPath

UNIVERSITY OF MINNESOTA

UNIVERSITY OF MINNESOTA logo
🇺🇸United States
Ownership
Private
Established
1851-01-01
Employees
10K
Market Cap
-
Website
http://www.umn.edu

PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant

Early Phase 1
Recruiting
Conditions
Focal Segmental Glomerulosclerosis
Interventions
Drug: Rituximab
Procedure: Plasmapheresis
First Posted Date
2018-12-04
Last Posted Date
2024-11-18
Lead Sponsor
University of Minnesota
Target Recruit Count
60
Registration Number
NCT03763643
Locations
🇺🇸

Duke University, Durham, North Carolina, United States

🇺🇸

University of Cincinnati, Cincinnati, Ohio, United States

🇺🇸

Seattle Children's Hospital, Seattle, Washington, United States

and more 9 locations

Scaling and Root Planing (SRP) With and Without Minocycline HCl Microspheres, 1 mg

Phase 4
Completed
Conditions
SRP
Minocycline HCl Microspheres
Biomarkers
Interventions
First Posted Date
2018-12-04
Last Posted Date
2024-03-25
Lead Sponsor
University of Minnesota
Target Recruit Count
70
Registration Number
NCT03762915
Locations
🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

Isometric Intervention for Lateral Elbow Tendinopathy

Phase 1
Withdrawn
Conditions
Elbow Sprain
Lateral Elbow Tendinopathy
Elbow Injury
Elbow Pain
Elbows Tendonitis
Interventions
Procedure: isometric intervention
First Posted Date
2018-11-28
Last Posted Date
2022-04-05
Lead Sponsor
University of Minnesota
Registration Number
NCT03756155
Locations
🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

Laryngeal Vibration for Spasmodic Dysphonia

Not Applicable
Completed
Conditions
Spasmodic Dysphonia
Interventions
Device: Laryngeal Vibration (Comparator)
Device: Laryngeal Vibration (Treatment)
First Posted Date
2018-11-19
Last Posted Date
2024-03-15
Lead Sponsor
University of Minnesota
Target Recruit Count
42
Registration Number
NCT03746509
Locations
🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

Telestroke for Comprehensive Transient Ischemic Attack Care in Acute Stroke Ready Hospitals

Completed
Conditions
Transient Ischemic Attack
Interventions
Other: Telestroke
First Posted Date
2018-10-30
Last Posted Date
2023-10-18
Lead Sponsor
University of Minnesota
Target Recruit Count
300
Registration Number
NCT03724110
Locations
🇺🇸

Fairview Ridges Hospital, Burnsville, Minnesota, United States

🇺🇸

Fairview Range Medical Center, Hibbing, Minnesota, United States

🇺🇸

Fairview Northland Medical Center, Princeton, Minnesota, United States

and more 2 locations

Sunfiber and the Microbiota

Not Applicable
Completed
Conditions
Diet Modification
Interventions
Dietary Supplement: Low fiber
Dietary Supplement: Placebo
Dietary Supplement: High fiber
First Posted Date
2018-10-29
Last Posted Date
2019-10-04
Lead Sponsor
University of Minnesota
Target Recruit Count
30
Registration Number
NCT03722862
Locations
🇺🇸

Department of Food Science and Nutrition, Saint Paul, Minnesota, United States

Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia

Phase 1
Completed
Conditions
Congenital Disorders
Adrenal Hyperplasia
Adrenocortical Hyperfunction
Congenital Adrenal Hyperplasia
Hydrocortisone
Genetic Diseases, Inborn
Steroid Metabolic Diseases, Inborn
Adrenal Gland Disease
Hyperplasia
Disorders of Sex Development
Interventions
Drug: Subcutaneous hydrocortisone
Drug: Standard glucocorticoid therapy
First Posted Date
2018-10-24
Last Posted Date
2023-07-20
Lead Sponsor
University of Minnesota
Target Recruit Count
11
Registration Number
NCT03718234
Locations
🇺🇸

Prism Clinical Research, Minneapolis, Minnesota, United States

Gum Acacia and Blood Glucose

Not Applicable
Completed
Conditions
Diet Modification
Interventions
Other: Placebo/Control
Other: Low Fiber
Other: High Fiber
First Posted Date
2018-10-23
Last Posted Date
2019-10-04
Lead Sponsor
University of Minnesota
Target Recruit Count
48
Registration Number
NCT03716479
Locations
🇺🇸

Department of Food Science and Nutrition, Saint Paul, Minnesota, United States

Ultrasound Treatment of Rheumatoid Arthritis

Not Applicable
Completed
Conditions
Rheumatoid Arthritis
Interventions
Device: Study device treatment
Device: Sham device treatment
First Posted Date
2018-10-01
Last Posted Date
2022-06-13
Lead Sponsor
University of Minnesota
Target Recruit Count
19
Registration Number
NCT03690466
Locations
🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

Spectroscopic Magnetic Resonance Imaging of Glioma

Recruiting
Conditions
Brain Tumor-Glioma
Interventions
Diagnostic Test: MEGA-PRESS sequence Magnetic Resonance Spectroscopy
First Posted Date
2018-09-19
Last Posted Date
2024-08-14
Lead Sponsor
University of Minnesota
Target Recruit Count
304
Registration Number
NCT03677999
Locations
🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath